EPHA5 mediates trastuzumab resistance in HER2‐positive breast cancers through regulating cancer stem cell‐like properties
2019 · The FASEB Journal · 31 citations
https://doi.org/10.1096/fj.201701561rrrr
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
33
Papers
408
Citations
11
h-index
12
i10-index
Mengzhu Yang is an academic researcher from Nanjing Medical University. The author has contributed to research in topics: HER2/EGFR in Cancer Research & Cancer Treatment and Pharmacology & Breast Cancer Treatment Studies. The author has an h-index of 11, co-authored 29 publications.
ORCID: 0000-0002-1086-2267https://doi.org/10.1096/fj.201701561rrrr
https://doi.org/10.1016/j.tranon.2026.102692
Click to start Chat